Franklin Resources’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-14,166
| Closed | -$1.44M | – | 2815 |
|
2023
Q2 | $1.44M | Buy |
14,166
+11,259
| +387% | +$1.15M | ﹤0.01% | 1515 |
|
2023
Q1 | $264K | Buy |
+2,907
| New | +$264K | ﹤0.01% | 1904 |
|
2022
Q4 | – | Sell |
-294,889
| Closed | -$7.41M | – | 2398 |
|
2022
Q3 | $7.41M | Sell |
294,889
-338,767
| -53% | -$8.51M | ﹤0.01% | 1006 |
|
2022
Q2 | $19.3M | Sell |
633,656
-218,502
| -26% | -$6.64M | 0.01% | 806 |
|
2022
Q1 | $27.9M | Sell |
852,158
-105
| -0% | -$3.44K | 0.01% | 763 |
|
2021
Q4 | $22.5M | Sell |
852,263
-172,035
| -17% | -$4.54M | 0.01% | 859 |
|
2021
Q3 | $103M | Sell |
1,024,298
-363,662
| -26% | -$36.6M | 0.04% | 466 |
|
2021
Q2 | $196M | Sell |
1,387,960
-71,829
| -5% | -$10.2M | 0.08% | 294 |
|
2021
Q1 | $146M | Sell |
1,459,789
-2,138
| -0.1% | -$213K | 0.06% | 342 |
|
2020
Q4 | $181M | Buy |
1,461,927
+68,273
| +5% | +$8.44M | 0.08% | 284 |
|
2020
Q3 | $136M | Buy |
1,393,654
+60,573
| +5% | +$5.9M | 0.07% | 314 |
|
2020
Q2 | $213M | Buy |
1,333,081
+131,210
| +11% | +$20.9M | 0.11% | 223 |
|
2020
Q1 | $174M | Sell |
1,201,871
-41,260
| -3% | -$5.96M | 0.12% | 205 |
|
2019
Q4 | $254M | Sell |
1,243,131
-11,896
| -0.9% | -$2.43M | 0.13% | 191 |
|
2019
Q3 | $101M | Buy |
1,255,027
+96,297
| +8% | +$7.73M | 0.05% | 369 |
|
2019
Q2 | $109M | Buy |
1,158,730
+179,994
| +18% | +$17M | 0.06% | 353 |
|
2019
Q1 | $83.7M | Buy |
978,736
+17,437
| +2% | +$1.49M | 0.04% | 411 |
|
2018
Q4 | $53.9M | Buy |
961,299
+102,286
| +12% | +$5.74M | 0.03% | 473 |
|
2018
Q3 | $70.2M | Buy |
859,013
+593,552
| +224% | +$48.5M | 0.04% | 458 |
|
2018
Q2 | $9.28M | Buy |
265,461
+27
| +0% | +$944 | ﹤0.01% | 932 |
|
2018
Q1 | $5.44M | Hold |
265,434
| – | – | ﹤0.01% | 1032 |
|
2017
Q4 | $7.52M | Buy |
265,434
+15,392
| +6% | +$436K | ﹤0.01% | 998 |
|
2017
Q3 | $7.78M | Buy |
+250,042
| New | +$7.78M | ﹤0.01% | 1004 |
|